Skip to content
10-K

Annual Report

BIOLARGO, INC. BLGO

0001437749-26-006926

← back to feed
Filed
Mar 4, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 2, 2026 319.75M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$8.3M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$3.21M
Cash And Equivalents FY 2025 · Dec 31, 2025 $3.88M
Cash And Equivalents FY 2025 · Dec 31, 2024 $3.55M
Stockholders Equity FY 2025 · Dec 31, 2025 $4.04M
Stockholders Equity FY 2025 · Dec 31, 2024 $8.85M
Current Liabilities FY 2025 · Dec 31, 2025 $5.06M
Current Liabilities FY 2025 · Dec 31, 2024 $2.65M
Total Liabilities FY 2025 · Dec 31, 2025 $6.79M
Total Liabilities FY 2025 · Dec 31, 2024 $4.46M
Current Assets FY 2025 · Dec 31, 2025 $5.11M
Current Assets FY 2025 · Dec 31, 2024 $7.14M
Total Assets FY 2025 · Dec 31, 2025 $8.31M
Total Assets FY 2025 · Dec 31, 2024 $10.51M
Eps Basic FY 2025 · Dec 31, 2025 −$0.04
Eps Basic FY 2025 · Dec 31, 2024 −$0.01
Sga Expense FY 2025 · Dec 31, 2025 $11.77M
Sga Expense FY 2025 · Dec 31, 2024 $9.3M
Rd Expense FY 2025 · Dec 31, 2025 $2.59M
Rd Expense FY 2025 · Dec 31, 2024 $2.88M
Operating Income FY 2025 · Dec 31, 2025 −$14.86M
Operating Income FY 2025 · Dec 31, 2024 −$4.33M
Gross Profit FY 2025 · Dec 31, 2025 $3.41M
Gross Profit FY 2025 · Dec 31, 2024 $7.85M